GlobeNewswire
-
Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
16/11/2026 -
Traws Pharma Reports Third Quarter 2026 Financial Results and Provides Business Highlights
16/11/2026 -
Olema Oncology to Participate in Upcoming Investor Conferences
16/11/2026 -
Precision Optics Reports First Quarter Fiscal 2027 Financial Results
16/11/2026 -
AEON Biopharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
16/11/2026 -
Genelux Corporation Reports Third Quarter Financial Results and Provides Business Updates
16/11/2026 -
Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
16/11/2026 -
Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
16/11/2026 -
Rosemont Pharmaceuticals to acquire Aytu BioPharma to accelerate US expansion
16/11/2026 -
Insight Molecular Diagnostics Announces Proposed Public Offering
16/11/2026 -
CervoMed Presents Interim Data at CTAD 2026 Showing Neflamapimod Reduces Neurodegeneration Biomarker in Nonfluent Variant Primary Progressive Aphasia
16/11/2026 -
Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
16/11/2026 -
Daré Bioscience Reports Third Quarter 2026 Financial Results and Highlights Commercial Execution and Pipeline Advancement
16/11/2026 -
Interpace Biosciences Announces Third Quarter 2026 Financial and Business Results
16/11/2026 -
Carlsmed to Participate in Upcoming Investor Conferences
16/11/2026 -
Asimov and Emergent Biosolutions Announce Cell Line Development Partnership to Advance Novel Antibodies Against Ebola
16/11/2026 -
Keros Therapeutics Announces Additional $5 Million Share Repurchase Authorization
16/11/2026 -
Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly
16/11/2026 -
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/11/2026
Pages